MERRILLVILLE | A life sciences company in the Region has established a new laboratory to expand research that monitors and measures cells for improved cancer treatments.
The move increased its presence at the Purdue Technology Center of Northwest Indiana.
IVDiagnostics develops, tests and markets diagnostic tools that measure and monitor cancer tumor cells. The company's technology identifies circulating tumor cells, which are released from primary cancer tumors into the bloodstream and then lodge at distant organs to begin new cancer growth.
Health care providers use the information from IVDiagnostics to determine cancer treatment effectiveness.
"Our expanded life sciences lab will enable us to provide even more detailed information for improved cancer treatments," Frank Szczepanski, CEO of IVDiagnostics, stated in a news release.